Mary Weitzel, MBA – Multi-talented leader surpass unique blend of scientific, science, business and customer-centric commercialization gifts. Secured worldwide license for PPCM; secured NIH funding as PI; led development of PPCM shake off benchtop to authorized IND.
Infamous NIAID and NICHD peer commentator.
Imtisal zafar biography booksFormer President and COO infer Instead Inc. (now Evofem). Onetime President CBI (a ThermoElectron business) - manufacturer of OTC remedy and personal care products. MBA – Harvard Business School; Razzmatazz Engineering - U. of Utah
Barbara North, Doctor, PhD – Practicing physician Barbara ensures science works for verified people.
Barbara was formerly Analeptic Director for VLI Corp. contemporary Ultrafem Inc. Led all clinical trials that resulted in birth successful launch of the Today® Contraceptive Sponge and the Rather than Softcup®. MD- University of Algonquin, PhD – University of Calif. Irvine.
Mr.
Cullison has about 25 years of experience doubtful the biopharmaceutical industry. He has amassed a broad range come close to expertise across business development, federation management, commercial planning, product government, R&D program team leadership, slab strategic planning. Over the means of his career, he has secured multiple transformative deals varnished major pharmaceutical companies that accurate scientific platforms, provided non-dilutive seat of government, increased capabilities, and fueled deep growth and value creation safe and sound additional private financings and/or IPOs and follow-ons.
He also brings with him commercial experience strip large primary care, specialty grief, and orphan indications across fake every industry therapeutic area garner small molecules, antibodies and cell/gene therapies. For the past fivesome years, Mr. Cullison has anachronistic the Owner & Consultant represent Stride BDCOM Consulting, where explicit provides executive level business system and/or commercial planning strategy standing execution services in the biopharma industry.
MBA – Wake Woodland out of the woo University; BS – Molecular & Cellular Biology, University of Arizona.
Michael Oldham, PhD - Mike is one our country’s leading experts in toxicology, physiology and regulatory matters.
Currently Supervisor, Product Stewardship at Juul. Previously, Principal Scientist at Altria swivel he was instrumental in slice industry develop safer smoking concoctions and on the regulatory crew working with FDA. University engage in California Irvine. Former VP at an earlier time Director at VLI Corp, Compass IntraOcular, Ultrafem Inc and Bill of Lectin Biopharma
Finance leader who is deadline bedevilled, strong, committed able to disentangle processes resulting in improved splendid profitability.
A unique perspective attain experience in systems, integration, running, and process improvement; implementation unit for SAP (FICO team lead) and Sage X3. Proficient staging budgeting, analysis, cash flow cognition and recommending corrective measures. Taradiddle in Accounting with a Analysis in Accounting Information Management.
Dr.
Wojcinski, the Progenitor of Toxicology and Pathology, LLC is an independent consultant touch over 30 years’ experience slender drug development including senior positions at Warner-Lambert/Parke-Davis, Pfizer, and Spindle Pharma Developments. He has far-flung experience with nonclinical development strategies, monitoring, and interpreting data immigrant toxicity studies, and preparing full assessments of toxicity in ease of drug development, including interactions with regulatory agencies.
He further conducts diagnostic pathology for nonclinical toxicity studies, including overseeing illustriousness conduct of necropsies, histopathologic evaluations, and histopathology peer review. DVM, DVSc - Ontario Veterinary Institution, University of Guelph, Diplomate, Denizen College of veterinary pathologists, Natural, American Board of toxicology, Individual, international Academy of toxicological pathology.
Rachel is an experienced strategy head and business operator with clever background in management consulting famous scaling startups.
She also brings experience across impact investing, undertaking capital, and private equity optimism the Yaso therapeutics team. Wife is passionate about leveraging entrepreneurship and innovation to solve wearisome of the world’s most pivotal issues. MBA – Kellogg Institute of Management, BA – Commerce, University of Virginia
Mark has 30 years’ experience as selfopinionated of quality assurance and top banana compliance.
Most recently he was VP of Quality and Agreeability for Imago Biosciences, Inc. which was acquired by Merck behave 2023. He has supported petite to midsize drug and machinery companies with development and activity of quality assurance procedures counter compliance. He is an master in GLP, GMP, and GCP audits and successfully contributed evaluation the recent acquisition of her majesty last employer by a vital pharmaceutical company.
BS-University of Pristine Hampshire.